Medical News

RSS

Curis announces inclusion in NASDAQ Biotechnology Index

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.

19 May 2010

St. Elizabeth Regional Health selects TeleHealth Services as compliance partner in new facility

TeleHealth Services, the nation's leading provider of health care grade televisions and interactive patient education solutions to hospitals, has been selected by St. Elizabeth Regional Health as a compliance partner in their new facility, St. Elizabeth East, located at 1701 S. Creasy Lane in Lafayette. St. Elizabeth East opened on February 25, 2010 and will benefit from TeleHealth's interactive educational solutions in an effort to increase patient satisfaction and create a patient-focused, technologically advanced facility.

19 May 2010

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.

19 May 2010

Essen BioScience launches CellPlayer Cell Migration 96-well assay kit

Essen BioScience Inc., a global provider of life science research tools and discovery services, today announced the launch of its CellPlayer™ Cell Migration 96-well assay kit for the IncuCyte™ Live-Cell Imaging System. The expanding line of kinetic CellPlayer assays for the IncuCyte also includes a co-culture assay for Angiogenesis.

From Sartorius 19 May 2010

Targacept commences Phase 2 clinical proof of concept trial of TC-5619 in adults with ADHD

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in adults with attention deficit/hyperactivity disorder (ADHD). TC-5619 is a novel small molecule that is highly selective for the alpha7 neuronal nicotinic receptor, which Targacept refers to as NNR, and was discovered by Targacept scientists using Targacept's proprietary drug discovery platform known as Pentad (TM).

19 May 2010

Boston Scientific announces U.S., European launches of Sterling SL PTA Balloon Dilatation Catheter

Boston Scientific Corporation today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.

19 May 2010

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.

19 May 2010

ABBOTT PRISM Chagas test receives FDA approval

Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."

19 May 2010

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Volcano Corporation announced today it received both 510(k) clearance and CE Mark approval for its PrimeWire PRESTIGE Pressure Guide Wire for use with patients who have both single-vessel and multi-vessel disease. This next generation pressure wire is compatible with Volcano's full suite of integrated multi-modality consoles and stand-alone physiology systems as well as various hemodynamic monitoring systems.

19 May 2010

Medical Properties Trust announces new $450 million credit facility

Medical Properties Trust, Inc. announced today that it has entered into a new $450 million credit facility with a syndicate of banks that replaces the Company's existing $220 million credit facility.

19 May 2010

Rosetta Genomics announces publication of study on discovery of microRNAs in solid tumors

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announces the publication of a study entitled, "Discovery of microRNAs and other small RNAs in solid tumors," in the online edition of Nucleic Acid Research.

19 May 2010

Riga to host 3rd Baltic Congress of Osteoporosis

Riga, Latvia will be the venue for the 3rd Baltic Congress of Osteoporosis which will take place on September 3-4, 2010. The congress, to be held in English, is jointly organized by the Latvian Osteoporosis and Bone Metabolism Diseases Association, Lithuanian Osteoporosis Foundation, Lithuanian Association of Metabolic Bone Diseases and the Estonian Osteoporosis Society.

19 May 2010

Experimental evolution used to develop new strains of bacteria for use as probiotic substances

When the forces of evolution took over an experimental strain of bacteria, it derailed an experiment Duke and NC State researchers thought they were conducting, but led to something much more profound instead.

19 May 2010

Plastic corneal prosthesis for patients unable to tolerate donor corneas

For many patients who become blind after an accident or illness, a corneal transplantation could restore the ability to see. Each year, 40,000 people in Europe - in Germany, about 7,000 - await the opportunity to be able to see again, thanks to cornea donors. But donor corneas are not common. Dr. Joachim Storsberg of the Fraunhofer Institute for Applied Polymer Research IAP in Potsdam-Golm developed material and production process for a corneal prosthesis made of plastic.

19 May 2010

BioTeknica, AccuReg help companies achieve realistic FDA compliance goals

Every year, the Food and Drug Administration (FDA), asks hundreds of life science companies to improve their design and manufacturing systems – or risk receiving the ultimate penalty – a Consent Decree; whereby a company must remove its products from the marketplace. It's not easy to navigate FDA regulations because they aren't always "black and white" – in fact; they're often "gray" and open to interpretation depending upon the circumstances.

19 May 2010

Children with new/recent onset epilepsy have slowed expansion of white matter volume

A newly published study reported that children with new/recent onset epilepsy have significantly slowed expansion of white matter volume compared to healthy children over a two year interval. The reduced white matter volume may affect brain connectivity and influence cognition. Results of this study conducted by researchers from the University of Wisconsin School of Medicine and Public Health are now available online and will appear in the July issue of Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

19 May 2010

HTDS commences subscription to Pink Sheets news and filing service

Hard to Treat Diseases, Inc. announces that the company has commenced to subscribe to Pink Sheets news and filing service after a brief absence.

19 May 2010

Abiomed's Impella revenue for full fiscal year 2010 up 59% to $57.8 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2010 revenue of $23.0 million, up 17% compared to revenue of $19.6 million for the same period of fiscal 2009.

19 May 2010

Work stress, economic pressures contribute to weight gain among U.S. labor force: Survey

The combination of work stress and economic pressures appears to be playing a role in the U.S. labor force's weight gain. Overall, 44 percent of workers say they have gained weight in their current jobs, up slightly from 43 percent in 2009, according to a new CareerBuilder survey. Nearly one-third (32 percent) of workers say that stress contributed to their weight gain at work.

19 May 2010

Pantai to implement Stockell Healthcare's InsightCS Patient Access and Revenue Cycle Management solution

Stockell Healthcare Systems, Inc. is pleased to announce that Pantai Holdings Berhad (Pantai) has chosen to implement its InsightCS® Patient Access and Revenue Cycle Management solution across a 10-hospital network located in Malaysia.

19 May 2010

Medical News

Curis announces inclusion in NASDAQ Biotechnology Index

St. Elizabeth Regional Health selects TeleHealth Services as compliance partner in new facility

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

Essen BioScience launches CellPlayer Cell Migration 96-well assay kit

Targacept commences Phase 2 clinical proof of concept trial of TC-5619 in adults with ADHD

Boston Scientific announces U.S., European launches of Sterling SL PTA Balloon Dilatation Catheter

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

ABBOTT PRISM Chagas test receives FDA approval

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Medical Properties Trust announces new $450 million credit facility

Rosetta Genomics announces publication of study on discovery of microRNAs in solid tumors

Riga to host 3rd Baltic Congress of Osteoporosis

Experimental evolution used to develop new strains of bacteria for use as probiotic substances

Plastic corneal prosthesis for patients unable to tolerate donor corneas

BioTeknica, AccuReg help companies achieve realistic FDA compliance goals

Children with new/recent onset epilepsy have slowed expansion of white matter volume

HTDS commences subscription to Pink Sheets news and filing service

Abiomed's Impella revenue for full fiscal year 2010 up 59% to $57.8 million

Work stress, economic pressures contribute to weight gain among U.S. labor force: Survey

Pantai to implement Stockell Healthcare's InsightCS Patient Access and Revenue Cycle Management solution

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News